Renal Associates, PA

San Antonio, Texas 78215-2035

1 studies enrolling now · 12 studies all time

What they study most

Alport Syndrome, Autosomal Recessive, Alport Syndrome, X-Linked, Anemia, Autosomal Dominant Polycystic Kidney, CKD Associated With Type 1 Diabetes, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Chronic Kidney Failure, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diabetic Nephropathy, Euvolemic Hyponatremia

Studies at this site

• EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety — Recruiting now
• A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX — Completed
• Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) — Completed
• Study of LY3016859 in Participants With Diabetic Nephropathy — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia — Completed
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa — Completed
• Bosutinib For Autosomal Dominant Polycystic Kidney Disease — Completed
• Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia — Completed
• A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease — Completed
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride — Stopped early